Globeflex Capital L P cut its holdings in Orthofix International N.V. (NASDAQ:OFIX) by 25.7% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,386 shares of the medical device company’s stock after selling 4,274 shares during the quarter. Globeflex Capital L P owned 0.07% of Orthofix International N.V. worth $576,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Pinebridge Investments L.P. lifted its stake in Orthofix International N.V. by 2.3% in the second quarter. Pinebridge Investments L.P. now owns 2,378 shares of the medical device company’s stock valued at $111,000 after buying an additional 53 shares during the period. State of Alaska Department of Revenue lifted its stake in Orthofix International N.V. by 79.3% in the second quarter. State of Alaska Department of Revenue now owns 3,551 shares of the medical device company’s stock valued at $165,000 after buying an additional 1,571 shares during the period. Mason Street Advisors LLC acquired a new position in Orthofix International N.V. in the first quarter valued at approximately $159,000. Municipal Employees Retirement System of Michigan acquired a new position in Orthofix International N.V. in the second quarter valued at approximately $196,000. Finally, Quantbot Technologies LP acquired a new position in Orthofix International N.V. in the first quarter valued at approximately $175,000. 94.40% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: This piece of content was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/09/28/orthofix-international-n-v-ofix-holdings-cut-by-globeflex-capital-l-p.html.

In other news, insider Bradley V. Niemann sold 6,956 shares of the firm’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $49.44, for a total value of $343,904.64. Following the completion of the transaction, the insider now owns 40,178 shares in the company, valued at approximately $1,986,400.32. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Rice Doug sold 7,353 shares of the firm’s stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $49.46, for a total value of $363,679.38. Following the completion of the transaction, the chief financial officer now owns 44,743 shares of the company’s stock, valued at approximately $2,212,988.78. The disclosure for this sale can be found here. In the last 90 days, insiders sold 23,406 shares of company stock valued at $1,138,531. 5.60% of the stock is currently owned by company insiders.

Shares of Orthofix International N.V. (NASDAQ OFIX) opened at 48.36 on Thursday. The company has a market cap of $878.70 million, a P/E ratio of 113.26 and a beta of 0.22. The stock’s 50 day moving average price is $47.80 and its 200 day moving average price is $43.18. Orthofix International N.V. has a 12-month low of $32.51 and a 12-month high of $50.40.

Orthofix International N.V. (NASDAQ:OFIX) last released its earnings results on Monday, August 7th. The medical device company reported $0.42 EPS for the quarter, beating the Zacks’ consensus estimate of $0.41 by $0.01. The company had revenue of $108.90 million during the quarter, compared to analysts’ expectations of $102.94 million. Orthofix International N.V. had a return on equity of 9.96% and a net margin of 1.88%. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.41 EPS. On average, analysts forecast that Orthofix International N.V. will post $1.56 EPS for the current year.

Several equities analysts have issued reports on OFIX shares. Ladenburg Thalmann Financial Services started coverage on Orthofix International N.V. in a research note on Wednesday, June 14th. They issued a “buy” rating and a $53.25 price target on the stock. Langenberg & Company reissued a “buy” rating and issued a $53.25 price target on shares of Orthofix International N.V. in a research note on Wednesday, June 14th. BTIG Research started coverage on Orthofix International N.V. in a research note on Wednesday, June 21st. They issued a “buy” rating and a $52.00 price target on the stock. Zacks Investment Research raised Orthofix International N.V. from a “sell” rating to a “hold” rating in a research note on Thursday, July 6th. Finally, BidaskClub lowered Orthofix International N.V. from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. Seven investment analysts have rated the stock with a buy rating, The company has an average rating of “Buy” and a consensus target price of $52.75.

Orthofix International N.V. Company Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Institutional Ownership by Quarter for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Stock Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related stocks with our FREE daily email newsletter.